Pharmaceutical Investing

Cardiome Announces Shareholder Meeting Voting Results

Pharmaceutical Investing

Horizon Pharma plc Completes Sale of European Subsidiary

Pharmaceutical Investing

Ovid Therapeutics to be Included in Russell Indexes

Pharmaceutical Investing

Karyopharm Reports Updated Phase 2b SADAL Data

Pharmaceutical Investing

NewLink Genetics To Present New Data from Phase 1b Study

Pharmaceutical Investing

Kalytera Announces Management Changes

Pharmaceutical Investing

Zogenix Obtains Orphan Drug Designation for ZX008

Pharmaceutical Investing

VistaGen Announces Publication of Clinical Study

Pharmaceutical Investing

DelMar Pharmaceuticals Receives Institutional Review Board Approval for Pivotal Phase 3 Clinical Trial of VAL-083 in Refractory GBM

Pharmaceutical Investing

Galectin Therapeutics Gets Patent for Use of GR-MD-02

Pharmaceutical Investing

Cardiome Announces Licensing Agreement for XYDALBA

Pharmaceutical Investing

Concordia Provides Update on Long-Term Growth Strategy

Pharmaceutical Investing

Latest pharmaceutical News

More pharmaceutical News

Outlook Reports world

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES